Israel stocks up 5th day; Teva report awaited
MarketWatch
Teva had "another solid and strong quarter, due to several new US generic product launches," Prevais, Allegra-D and the relaunch of Pulmicort after a legal

and more »

Teva Pharmaceutical Industries Limited Q4 2009 Earnings Call Transcript
Seeking Alpha (blog)
These launches included one significant new generic product, Adderall XR, and the rare introduction of another pulmicort. We were highly focused during the

and more »

TopNews New Zealand

Watson Pharmaceuticals, Inc. Q4 2009 Earnings Call Transcript
Seeking Alpha (blog)
ANDA also benefited from the relaunch in the quarter of generic Pulmicort as well as an increase in third-party Brand sales. And with that I'll turn the
Watson Reports Net Revenue of $786 Million for the Fourth Quarter 2009MarketWatch (press release)

all 69 news articles »

BBC News
AstraZeneca overhaul leaves 550 jobless
The News Journal
AstraZeneca said it anticipated a "mid-single-digit decline in revenue" in 2010 as breast cancer drug Arimidex and asthma medicine Pulmicort Respules face
Strong medicine for AstraZeneca as 1200 UK jobs goManagement Today

all 273 news articles »

AstraZeneca Chief Talks Pharma Challenges
BusinessWeek
Mr Brennan concedes that the loss of exclusivity on the breast cancer drug Arimidex and the asthma medicine Pulmicort Respules will squeeze revenues,

and more »

Israel stocks up 5th day; Teva report awaited
MarketWatch
Teva had "another solid and strong quarter, due to several new US generic product launches," Prevais, Allegra-D and the relaunch of Pulmicort after a legal

and more »

This Is Not Your Generic Cash Production
Motley Fool
and the reintroduction of Teva's version of AstraZeneca's (NYSE: AZN) Pulmicort Respules helped contribute to the strong cash flow, as did the growth of

and more »

New Lilly R&D chief plans bold moves to recharge pipeline
Indianapolis Star
And the pinch is expected to get tighter this year, when cancer drug Arimidex and asthma drug Pulmicort lose their patents. Lundberg doesn't apologize for

and more »

AstraZeneca agrees to pay £505m to settle 15-year tax battle
Independent
worldwide operations as treatments such as the breast cancer drug Arimidex and the asthma medicine Pulmicort Respules are opened to generic competition.

and more »

Watson Beats, Maintains Guidance
Zacks.com
increased 22% to $197.4 million in the quarter, mainly due to sales of generic versions of Valtrex and Prevacid and the re-launch of generic Pulmicort.

and more »

Intendis y AstraZeneca firman un acuerdo para copromocionar Pulmicort en pediatría
acceso.com (Comunicado de prensa)
Madrid, 26 de Febrero de 2010 – La División Intendis del Grupo Bayer, ha firmado un acuerdo con AstraZeneca en España para promocionar Pulmicort en

TopNews New Zealand

Watson Pharmaceuticals, Inc. Q4 2009 Earnings Call Transcript
Seeking Alpha (blog)
ANDA also benefited from the relaunch in the quarter of generic Pulmicort as well as an increase in third-party Brand sales. And with that I'll turn the
Watson Reports Net Revenue of $786 Million for the Fourth Quarter 2009MarketWatch (press release)

all 69 news articles »

BBC News
AstraZeneca overhaul leaves 550 jobless
The News Journal
AstraZeneca said it anticipated a "mid-single-digit decline in revenue" in 2010 as breast cancer drug Arimidex and asthma medicine Pulmicort Respules face
Strong medicine for AstraZeneca as 1200 UK jobs goManagement Today

all 273 news articles »

Israel stocks up 5th day; Teva report awaited
MarketWatch
Teva had "another solid and strong quarter, due to several new US generic product launches," Prevais, Allegra-D and the relaunch of Pulmicort after a legal

and more »

AstraZeneca Chief Talks Pharma Challenges
BusinessWeek
Mr Brennan concedes that the loss of exclusivity on the breast cancer drug Arimidex and the asthma medicine Pulmicort Respules will squeeze revenues,

and more »

This Is Not Your Generic Cash Production
Motley Fool
and the reintroduction of Teva's version of AstraZeneca's (NYSE: AZN) Pulmicort Respules helped contribute to the strong cash flow, as did the growth of

and more »

New Lilly R&D chief plans bold moves to recharge pipeline
Indianapolis Star
And the pinch is expected to get tighter this year, when cancer drug Arimidex and asthma drug Pulmicort lose their patents. Lundberg doesn't apologize for

and more »

AstraZeneca agrees to pay £505m to settle 15-year tax battle
Independent
worldwide operations as treatments such as the breast cancer drug Arimidex and the asthma medicine Pulmicort Respules are opened to generic competition.

and more »

Watson Beats, Maintains Guidance
Zacks.com
increased 22% to $197.4 million in the quarter, mainly due to sales of generic versions of Valtrex and Prevacid and the re-launch of generic Pulmicort.

and more »

Intendis y AstraZeneca firman un acuerdo para copromocionar Pulmicort en pediatría
acceso.com (Comunicado de prensa)
Madrid, 26 de Febrero de 2010 – La División Intendis del Grupo Bayer, ha firmado un acuerdo con AstraZeneca en España para promocionar Pulmicort en

TopNews New Zealand

This Is Not Your Generic Cash Production
Motley Fool
Whatever Teva decides to do, given management's track record, investors should be confident in letting management use the cash to reinvest in the business

and more »

New Lilly R&D chief plans bold moves to recharge pipeline
Indianapolis Star
And the pinch is expected to get tighter this year, when cancer drug Arimidex and asthma drug Pulmicort lose their patents. Lundberg doesn't apologize for

and more »

TopNews New Zealand

AstraZeneca overhaul leaves 550 jobless
The News Journal
AstraZeneca said it anticipated a "mid-single-digit decline in revenue" in 2010 as breast cancer drug Arimidex and asthma medicine Pulmicort Respules face

and more »

AstraZeneca Chief Talks Pharma Challenges
BusinessWeek
Mr Brennan concedes that the loss of exclusivity on the breast cancer drug Arimidex and the asthma medicine Pulmicort Respules will squeeze revenues,

and more »

Teva Pharmaceutical Industries Limited Q4 2009 Earnings Call Transcript
Seeking Alpha (blog)
These launches included one significant new generic product, Adderall XR, and the rare introduction of another pulmicort. We were highly focused during the

and more »